Whitepapers

This work aims to develop and optimize a liquid chromatography (LC) ddMS2 method for the untargeted analysis of oligonucleotides using Orbitrap-based HRAM MS.

This on-demand webinar shows how to connect unintegrated equipment to achieve real-time visibility across production, centralized recipe management, and batch reporting.

After a disruptive year in the pharma industry, it’s time to adapt to the next normal. Learn about the four main trends shaping the evolving industry.

Pharmaceutical packaging testing is carried out to guarantee suitability of drug packaging for intended uses. Read the Jordi Labs whitepaper to learn more.

Download this buyer's guide to learn more about TruCLEAN cleanroom mops and discover the tools and insights you need to form a compliant cleaning program.

This white paper explains the theory behind the MCA algorithm methodology. Then, used in tandem with in-situ fiber optics, the accuracy of the technique is demonstrated.

The update for EU annex 1 is more than a simple revision, solidifying the expectation that facility fully understand their processes and systems.  

The Virsa Raman analyser is ideal for fiber analysis; whether in a laboratory setting or in industrial research, development or quality assurance.

Formulators must have an empirical methodology to characterize the properties of neat materials/blends to ensure the formulation meets the target product profile.

This whitepaper describes the microencapsulation process of coacervation using both aqueous and solvent pathways, and the many benefits for drug developers.

This note describes a rapid method for the evaluation of sediment redispersibility in less than 30 minutes using the Turbiscan technology.

Eurofins BioPharma Product Testing offers a 5-day rapid mycoplasma test comparable in sensitivity and specificity to the 28-day compendial method.

In this application note, we pair Simple Plex Assays on Ella with Cygnus 3G CHO antibodies for superior sensitivity and data reproducibility throughout bioproduction.

This white paper demonstrates a vendor’s perspective on recent trends in regulations and the potential future direction for the industry.

Bring vaccines and therapies to market faster through earlier production control planning, standard pre-structured automation designs, and advanced technology. 

This paper answers a major concern of manufacturers: Do x-rays affect the quality and efficacy of a drug during product inspection?